The maternal death rate in the US could be reduced if all women undergoing cesarean delivery received thromboembolism prophylaxis.
The maternal death rate in the United States could be systematically reduced if all women undergoing caesarean delivery received thromboembolism prophylaxis, according to research published in the July issue of the American Journal of Obstetrics and Gynecology.
Steven L. Clark, MD, of the Hospital Corporation of America in Nashville, TN, and colleagues reviewed 2000–2006 data on nearly 1.5 million pregnancies, including 95 that resulted in maternal death.
The researchers identified complications of preeclampsia, pulmonary thromboembolism, amniotic fluid embolism, obstetric hemorrhage, and cardiac disease as the leading causes of maternal death, and concluded that only 28% of deaths were preventable because they resulted from errors committed by health-care and non-health-care personnel. They also found that the rate of maternal death causally related to the mode of delivery was higher for cesarean than for vaginal delivery (2.2 vs. 0.2 per 100,000 deliveries).
Clark SL, Belfort MA, Dildy GA, et al. Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery. Am J Obstet Gynecol. 2008;199:36.e1-36.e5
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More